Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that a higher waist-hip ratio significantly increases the risk of metabolic syndrome in women with PCOS.

The enzyme 5α-reductase is important for proper blood vessel development during the fertility-related transformation of the uterus lining.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

DNA methylation changes in women with PCOS could be used as disease markers and suggest new treatment targets.

Women with PCOS have thicker parafoveal areas in their retinas, but their macular blood vessel density is normal.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Menopausal acne is treated with medications and lifestyle changes, but careful choice is needed due to side effects.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

The study found that PCOS affects about 6.5-6.8% of women in both urban and rural areas of Telangana, India, and highlighted the importance of lifestyle changes for management.

Acanthosis nigricans in teenage girls with PCOS is a sign of obesity, not insulin resistance or glucose intolerance.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

The birth control combination of ethinylestradiol and drospirenone helps treat symptoms of polycystic ovary syndrome.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Agaricus subrufescens improves ovarian function and biochemical health in rats with PCOS.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Masculine facial features may not reliably indicate heritable health, and more research is needed.

Metformin improves quality of life, emotional health, and sex life in women with polycystic ovary syndrome.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Polycystic Ovary Syndrome (PCOS) affects Iranian women's feelings of femininity and self-image.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

The document concludes that more research is needed to understand how PRP affects the ovaries and to standardize its use in treatment.

The review suggests new ways to classify ejaculation problems and recommends different treatments based on the type of issue.

A woman's high testosterone levels and related symptoms improved after ovary removal surgery.

Genetic risk for PCOS can affect children's growth, metabolism, and development from early life into adulthood.

Girls with PCOS during adolescence have a higher risk of developing type 2 diabetes, and early treatment can help manage this risk.

A 33-year-old woman with PCOS and metabolic syndrome was unusually diagnosed with a bone condition called DISH, suggesting a possible link between these conditions.

Oestrogens help maintain healthy skin, heal wounds, and may protect against skin aging and cancer.

The research suggests that the global distribution of PCOS is likely due to historical human migration and that genes affecting PCOS may have different impacts on males and females.